A novel approach to prevent Alzheimer, Parkinson and ALS diseases phenotypes in situ and in transgenic mice models using a small peptide derived from cyclin-dependent kinase 5 (Cdk5) neuron specific activator protein, p35
have designed several small peptides of p25 on the basis of Cdk5/ p25 crystal structure and molecular modeling, evaluated for competition with p25 and thus inhibiting selectively the hyperactivity ... amino acids…

